Insulet(FRA) GOV

Market Cap€8.66B

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€127.40

+2.04%

+2.55Today

Insulet Financials at a Glance

Market Cap

€8.66B

Revenue (TTM)

€2.62K

Net Income (TTM)

€321.82

EPS (TTM)

€4.32

P/E Ratio

28.87

Dividend

€0.00

Beta (Volatility)

-0.16 (Low)

Dividend

€0.00

Beta (Volatility)

-0.16 (Low)

Price

€127.40

Volume

Open

€124.05

Price

€127.40

Volume

Open

€124.05

Previous Close

€127.40

Daily Range

€121.80 - €128.00

52-Week Range

€112.45 - €304.00

Estimated Earnings Date

N/A

Dividend

€0.00

Beta (Volatility)

-0.16 (Low)

Price

€127.40

Volume

Open

€124.05

Previous Close

€127.40

Daily Range

€121.80 - €128.00

52-Week Range

€112.45 - €304.00

Estimated Earnings Date

N/A

GOV News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Insulet

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

5,400

CEO

Ashley A. McEvoy

Website

www.insulet.com

GOV Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

25.85%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

3.46%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€8.66B

Shares Outstanding

69.35M

Volume

Avg. Volume

28.788

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Insulet Performance Analysis

Insulet annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 1,241,990,389	33.6%
2023	2023-12-31	EUR 1,569,767,373	26.4%
2024	2024-12-31	EUR 1,915,149,952	22.0%
2025	2025-12-31	EUR 2,399,568,411	25.3%

Insulet annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR 0.06	-69.8%
2023	2023-12-31	EUR 2.72	4248.6%
2024	2024-12-31	EUR 5.35	96.4%
2025	2025-12-31	EUR 3.08	-42.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€689.51

+1.2%

Gross Profit

€500.30

+1.2%

Gross Margin

72.56%

+1.0%

Market Cap

€8.66B

N/A

Market Cap/Employee

€1.71

N/A

Employees

5,400

N/A

Net Income

€81.71

+4.1%

EBITDA

€140.02

+1.1%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€1.30K

-36.8%

Total Debt

€829.53

+0.7%

Accounts Receivable

€514.91

+1.4%

Inventory

€424.04

+1.1%

Long Term Debt

€813.00

+1.0%

Short Term Debt

€16.53

+0.0%

Return on Assets

11.25%

+1.5%

Return on Invested Capital

7.41%

+1.4%

Free Cash Flow

€48.64

+0.3%

Operating Cash Flow

€76.72

+0.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About GOV

What is the current price of Insulet?

Insulet is trading at €127.40 per share.

What is the 52-week range for Insulet?

Over the past 52 weeks, Insulet has traded between €112.45 and €304.00.

How much debt does Insulet have?

As of the most recent reporting period, Insulet reported total debt of €829.53M.

How much cash does Insulet have on hand?

Insulet reported €467.86M in cash and cash equivalents in its most recent financial results.

What is Insulet’s dividend yield?

Insulet does not currently have a dividend yield.

Insulet(FRA) GOV

Insulet Financials at a Glance

GOV News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Insulet

GOV Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Insulet Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About GOV

What is the current price of Insulet?

What is the 52-week range for Insulet?

How much debt does Insulet have?

How much cash does Insulet have on hand?

What is Insulet’s dividend yield?

Premium Investing Services